Show Summary Details
Page of

Perioperative cardioprotection 

Perioperative cardioprotection
Perioperative cardioprotection

ML Riess

and JR Kersten

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 27 January 2021

Chapter 9 covers perioperative cardioprotection, and features Ten key investigations that highlight the progress in basic and clinical science in this area. In the last 10–15 years, a growing body of evidence has indicated that a variety of pharmacological approaches to decrease cardiovascular risk in patients with coronary artery disease exist including pre- and postconditioning with volatile anaesthetics; the use of noble gases to trigger endogenous cardioprotective signalling without producing loss of consciousness or hypotension; statin therapy to favourably modulate cardiovascular biology that may be both dependent and independent of cholesterol lowering; and judicious use of beta-blockers titrated to achieve maximum efficacy, but with a low risk for adverse effects.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.